In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas
Esther de Boer(University Medical Center Groningen), Margaret Brandwein‐Gensler(University of Alabama at Birmingham), Kurt R. Zinn(University of Alabama at Birmingham), Lindsay S. Moore(University of Alabama at Birmingham), Yolanda E. Hartman(University of Alabama at Birmingham), Melissa L. Korb(University of Alabama at Birmingham), Jason M. Warram(University of Alabama at Birmingham), Eben L. Rosenthal(Vanderbilt University Medical Center), Matthew D. Tucker(University of Alabama at Birmingham), Thomas K. Chung(University of Alabama at Birmingham), Johannes S. de Jong(Utrecht University), Gooitzen M. van Dam(Polpharma Biologics (Netherlands))
Cited by 101
Related Papers
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
|Clinical Cancer Research|2015|477
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
|Blood|2007|328
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung
|Nature Biotechnology|2007|305
Validation of the Histologic Risk Model in a New Cohort of Patients With Head and Neck Squamous Cell Carcinoma
|The American Journal of Surgical Pathology|2010|228